|
|
||||||||
1 Anatomisches Institut, Charité, Humboldt Universität, 13353 Berlin, Germany; and 2 Department of Pediatric Surgery, Erasmus University, 3000 DR Rotterdam, The Netherlands
This study
describes elevated histochemical signals for nitric oxide synthase-1
(NOS1) and cyclooxygenase-2 (COX-2) in juxtaglomerular apparatus (JGA)
and adjacent thick ascending limb of the kidney of fawn-hooded
hypertensive rats (FHH). Two different age groups of FHH (8 and 16 wk;
FHH8 and FHH16, respectively) were compared with genetically related
fawn-hooded rats with normal blood pressure (FHL) that served as
controls. Histopathological changes in FHH comprised focal segmental
glomerulosclerosis (FSGS), focal matrix overexpression, and a moderate
arteriolopathy with hypertrophy of the media, enhanced immunoreactivity
for
-smooth muscle actin, and altered distribution of myofibrils.
Macula densa NOS activity, as expressed by NADPH-diaphorase staining,
and NOS1 mRNA abundance were significantly elevated in FHH8 (+153 and
+88%; P < 0.05) and FHH16 (+93 and +98%;
P < 0.05), respectively. Even higher elevations were
registered for COX-2 immunoreactivity in FHH8 (+166%;
P < 0.05) and FHH16 (+157%; P < 0.05). The intensity of renin immunoreactivity and renin mRNA
expression in afferent arterioles was also elevated in FHH8 (+51 and
+166%; P < 0.05) and FHH16 (+105 and +136%;
P < 0.05), respectively. Thus we show that coordinate upregulation of tubular NOS1, COX-2, and renin expression precedes, and
continues after, the manifestation of glomerulosclerotic damage in FHH.
These observations may have implications in understanding the role of
local paracrine mediators in glomerular disease.
juxtaglomerular apparatus; macula densa; nitric oxide; prostaglandins; renin
This article has been cited by other articles:
![]() |
L. G. Sanchez-Lozada, E. Tapia, V. Soto, C. Avila-Casado, M. Franco, L. Zhao, and R. J. Johnson Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1179 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Just Mechanisms of renal blood flow autoregulation: dynamics and contributions Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R1 - R17. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Paliege, A. Parsumathy, D. Mizel, T. Yang, J. Schnermann, and S. Bachmann Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R694 - R700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. R. Goncalves, C. K. Fujihara, A. L. Mattar, D. M. A. C. Malheiros, I. L. Noronha, G. de Nucci, and R. Zatz Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory Am J Physiol Renal Physiol, May 1, 2004; 286(5): F945 - F954. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |